Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Step in Style: A Survey of \Solace and Execution on the Track\ Running Shoes - 2How mountain terraces have helped Indigenous peoples live with climate uncertainty
- 3Everything you should know before booking a trip to Spain
- 4'The Beast in Me' arrives on Netflix: Is it based on a true story? And what drew Claire Danes to it? What to know about the thriller series.
- 5Israel launches new wave of attacks against Hezbollah in Beirut
- Hamas set to elect new terror leader with Hayya, Mashaal in pole position
- German finance minister sees advantages of smartphones in schools
- Instructions to Perform Fundamental Upkeep on Your Slam 1500.
- Did Japan’s PM Actually Back the Memecoin Bearing Her Name?
- Are protests pushing Iran's Islamic regime toward a tipping point?
- 10 Asian Countries Perfect for Solo Female Travelers
- Family Holiday spots
- Nigeria police charge Joshua driver with dangerous driving over fatal crash
- Amazon sued over 'punitive' handling of employee absences
